Go offline with the Player FM app!
#106 Five TechBio Myths That Must Go — Guillermo Vela (Co-Founder NeuScience)
Manage episode 346470831 series 2663557
Guillermo Vela is the CEO and Co-Founder of NeuScience, a VC-backed TechBio company using AI to discover novel cancer biomarkers.
0:00 Intro
0:55 Eroom's Law
5:37 Contrarian View of Cancer
15:54 AI Will Not Make Drug Discovery Fast, Better or Cheaper
26:14 Failing is Not a Good Thing
26:38 TechBio Funding
34:07 Habits
He went viral, in the techbio scene, with his 'Five TechBio Myths That Must Go' article in which he explained why it doesn’t take $2.5bn to develop a drug and why technologies like AI wont’ make drug discovery faster, better or cheaper. We discuss that article, we discuss Guillermo’s contrarian view of cancer, why we’re doing more science than ever but not seeing results and how his ADD brain is a superpower.
I hope you enjoy.
You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io
149 episodes
Manage episode 346470831 series 2663557
Guillermo Vela is the CEO and Co-Founder of NeuScience, a VC-backed TechBio company using AI to discover novel cancer biomarkers.
0:00 Intro
0:55 Eroom's Law
5:37 Contrarian View of Cancer
15:54 AI Will Not Make Drug Discovery Fast, Better or Cheaper
26:14 Failing is Not a Good Thing
26:38 TechBio Funding
34:07 Habits
He went viral, in the techbio scene, with his 'Five TechBio Myths That Must Go' article in which he explained why it doesn’t take $2.5bn to develop a drug and why technologies like AI wont’ make drug discovery faster, better or cheaper. We discuss that article, we discuss Guillermo’s contrarian view of cancer, why we’re doing more science than ever but not seeing results and how his ADD brain is a superpower.
I hope you enjoy.
You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io
149 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.